GSK plc (GSK.L) News Headlines

▮ More

Date

Headline

9/26/2022 3:05:24 AM GSK Names Julie Brown New CFO As Iain Mackay Retires

9/26/2022 2:08:21 AM GSK CFO Iain Mackay To Retire

9/22/2022 11:03:28 AM GSK : FDA Panel To Review Zejula Data From Phase III Trial In Recurrent Ovarian Cancer

9/22/2022 2:33:57 AM GSK To Receive Licence From Spero To Develop, Commercialise Tebipenem Pivoxil HBr

9/22/2022 2:09:34 AM GSK, Spero Therapeutics Announce Licence Agreement For Tebipenem HBr

9/19/2022 6:42:09 AM Theravance To Buy Back $250 Mln Of Shares

9/19/2022 6:06:53 AM Theravance Biopharma Agrees To Purchase GSK's Entire Holdings At $9.75/Shr

9/6/2022 9:36:05 AM GSK: FDA Sets Advisory Committee Meeting To Review NDA For Daprodustat - Quick Facts

9/6/2022 8:41:23 AM GSK Announces Update On FDA Regulatory Review Of Daprodustat In Anaemia Of Chronic Kidney Disease

8/29/2022 6:24:07 AM IDEAYA Reports Preclinical Development Milestone In Ongoing IND-enabling Studies With GSK

8/24/2022 2:03:33 AM GSK Plc Appoints Elizabeth McKee Anderson As Non-Executive Director

8/17/2022 2:43:54 AM GSK: FDA Accepts New Drug Application For Momelotinib To Treat Myelofibrosis

8/17/2022 2:19:59 AM GSK Plc Issues Statement On Voluntary Dismissal To Be Filed In Bayer Case

8/17/2022 2:09:26 AM GSK Says FDA Accepts New Drug Application For Momelotinib For Treatment Of Myelofibrosis

8/16/2022 3:16:00 AM GSK Concludes Acquisition Of Affinivax

8/16/2022 2:11:27 AM GSK Completes Acquisition Of Affinivax

8/12/2022 2:41:45 AM GSK: FDA, EMA Conclude No Evidence Of Association Between Ranitidine Therapy And Cancer Development

8/12/2022 2:03:57 AM GSK Plc Issues Statement On Zantac Litigation

7/27/2022 3:06:04 AM GSK Q2 Pre-tax Profit Down, But Lifts FY Outlook

7/27/2022 2:18:03 AM GSK Q2 Sales £6.9 Bln, Up 19% At AER

Gsk Plc (GSK.L)